The serum concentration of Deflazacort can be increased when it is combined with Ethinyl Estradiol. The therapeutic efficacy of Deoxyspergualin can be decreased when used in combination with Dienogest. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Cilazapril. The serum concentration of Anecortave can be increased when it is combined with Ethinyl Estradiol. The metabolism of Dienogest can be decreased when combined with Venlafaxine. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Artemether. The serum concentration of Theophylline can be increased when it is combined with Ethinyl Estradiol. The therapeutic efficacy of Ancrod can be decreased when used in combination with Dienogest. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Elafin. The metabolism of Ethinyl Estradiol can be decreased when combined with Ticlopidine. The metabolism of Ethinyl Estradiol can be increased when combined with Phenobarbital. The serum concentration of Fluocortolone can be increased when it is combined with Ethinyl Estradiol. The therapeutic efficacy of Insulin Human can be decreased when used in combination with Dienogest. The metabolism of Dienogest can be decreased when combined with Verapamil. The metabolism of Ethinyl Estradiol can be increased when combined with Rifabutin. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Gabexate. Ethinyl Estradiol may decrease the anticoagulant activities of Protocatechualdehyde. The serum concentration of Dienogest can be decreased when it is combined with Mitotane. Oleandrin may decrease the cardiotoxic activities of Dienogest. The therapeutic efficacy of Miglustat can be decreased when used in combination with Dienogest. Ethinyl Estradiol may decrease the anticoagulant activities of Protein S human. The therapeutic efficacy of Ciglitazone can be decreased when used in combination with Dienogest. Ethinyl Estradiol may decrease the anticoagulant activities of Troxerutin. The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ethinyl Estradiol. Dienogest may decrease the anticoagulant activities of Phenprocoumon. The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Dienogest. The therapeutic efficacy of Heparin can be decreased when used in combination with Dienogest. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Prucalopride. The serum concentration of 5-androstenedione can be increased when it is combined with Ethinyl Estradiol. Digoxin Immune Fab (Ovine) may decrease the cardiotoxic activities of Dienogest. Ethinyl Estradiol may decrease the anticoagulant activities of Dextran 40. Ethinyl Estradiol may increase the thrombogenic activities of Conestat alfa. The therapeutic efficacy of Acarbose can be decreased when used in combination with Ethinyl Estradiol. The serum concentration of Dienogest can be increased when it is combined with Osimertinib. The metabolism of Dienogest can be decreased when combined with Cyclosporine. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Cholesterol. The therapeutic efficacy of Anastrozole can be decreased when used in combination with Ethinyl Estradiol. The metabolism of Ethinyl Estradiol can be decreased when combined with Clotrimazole. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with 1,10-Phenanthroline. Ouabain may decrease the cardiotoxic activities of Dienogest. The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Dienogest. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Ulinastatin. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Racecadotril. The therapeutic efficacy of Allicin can be decreased when used in combination with Dienogest. The therapeutic efficacy of Dienogest can be decreased when used in combination with Secobarbital. The metabolism of Dienogest can be increased when combined with Rifapentine. The serum concentration of Desoxycorticosterone Pivalate can be increased when it is combined with Ethinyl Estradiol. The serum concentration of HE3286 can be increased when it is combined with Ethinyl Estradiol. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Temocapril. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Phosphoramidon. Acetyldigitoxin may decrease the cardiotoxic activities of Dienogest. The metabolism of Dienogest can be decreased when combined with Ranolazine. The serum concentration of Equilenin can be increased when it is combined with Ethinyl Estradiol. The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Methohexital. The metabolism of Ethinyl Estradiol can be decreased when combined with Diltiazem. The metabolism of Ethinyl Estradiol can be decreased when combined with Ziprasidone. The serum concentration of Dienogest can be increased when it is combined with Telithromycin. The metabolism of Ethinyl Estradiol can be decreased when combined with Lovastatin. The serum concentration of Ethinyl Estradiol can be increased when it is combined with Osimertinib. The serum concentration of Dienogest can be decreased when it is combined with Felbamate. The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Ethinyl Estradiol. The serum concentration of Ethinyl Estradiol can be increased when it is combined with Ranolazine. Ethinyl Estradiol may decrease the anticoagulant activities of Danaparoid. The therapeutic efficacy of Letaxaban can be decreased when used in combination with Dienogest. The metabolism of Dienogest can be decreased when combined with Delavirdine. The serum concentration of Dienogest can be decreased when it is combined with Nelfinavir. The therapeutic efficacy of Dienogest can be decreased when used in combination with Alitretinoin. The therapeutic efficacy of Voglibose can be decreased when used in combination with Ethinyl Estradiol. The therapeutic efficacy of Lepirudin can be decreased when used in combination with Dienogest. The metabolism of Ethinyl Estradiol can be decreased when combined with Venlafaxine. The serum concentration of Dienogest can be decreased when it is combined with Cholestyramine. The metabolism of Ethinyl Estradiol can be decreased when combined with Indinavir. The metabolism of Dienogest can be decreased when combined with Rucaparib. The metabolism of Ethinyl Estradiol can be decreased when combined with Delavirdine. Digoxin may decrease the cardiotoxic activities of Dienogest. The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Ethinyl Estradiol. The serum concentration of Dienogest can be decreased when it is combined with Dabrafenib. The therapeutic efficacy of Reviparin can be decreased when used in combination with Dienogest. Bevacizumab may increase the cardiotoxic activities of Dienogest. The metabolism of Dienogest can be decreased when combined with Sulfisoxazole. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. Dienogest may decrease the anticoagulant activities of Fluindione. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Enzalutamide. The therapeutic efficacy of Dienogest can be decreased when used in combination with Methohexital. The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Ethinyl Estradiol. The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Alitretinoin. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Benzamidine. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Boceprevir. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Fosaprepitant. The metabolism of Ethinyl Estradiol can be decreased when combined with Verapamil. The therapeutic efficacy of Castanospermine can be decreased when used in combination with Dienogest. The serum concentration of Ethinyl Estradiol can be increased when it is combined with Vemurafenib. Deslanoside may decrease the cardiotoxic activities of Dienogest. The serum concentration of Dienogest can be decreased when it is combined with Deferasirox. The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Dienogest. The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Thiopental. The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Ethinyl Estradiol. The metabolism of Dienogest can be decreased when combined with Isradipine. The serum concentration of Flunisolide can be increased when it is combined with Ethinyl Estradiol. The serum concentration of Fluprednidene can be increased when it is combined with Ethinyl Estradiol. The therapeutic efficacy of Nateglinide can be decreased when used in combination with Dienogest. The serum concentration of Dienogest can be decreased when it is combined with Mycophenolic acid. The therapeutic efficacy of Troxerutin can be decreased when used in combination with Dienogest. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with S-3304. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Darexaban. The metabolism of Dienogest can be decreased when combined with Diltiazem. The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Phenytoin. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Lisinopril. The therapeutic efficacy of Glipizide can be decreased when used in combination with Ethinyl Estradiol. The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Dienogest. The serum concentration of Dienogest can be increased when it is combined with Clarithromycin. The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Barbital. The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Ethinyl Estradiol. Lumiracoxib may increase the thrombogenic activities of Ethinyl Estradiol. The serum concentration of Oleoyl-estrone can be increased when it is combined with Ethinyl Estradiol. The serum concentration of Ethinyl Estradiol can be increased when it is combined with Simeprevir. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Nafamostat. The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Ethinyl Estradiol. The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Ethinyl Estradiol. The therapeutic efficacy of Ethinyl Estradiol can be decreased when used in combination with Thiamylal. The therapeutic efficacy of Abciximab can be decreased when used in combination with Dienogest. The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Dienogest. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Bexarotene. The serum concentration of Ethinyl Estradiol can be decreased when it is combined with Oxcarbazepine. The metabolism of Ethinyl Estradiol can be decreased when combined with Bortezomib. The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Dienogest. The metabolism of Dienogest can be decreased when combined with Ticlopidine. The metabolism of Dienogest can be decreased when combined with Ziprasidone. The serum concentration of Desonide can be increased when it is combined with Ethinyl Estradiol.